Cargando…

Protective Effect of HER2 Gene Polymorphism rs24537331 in the Outcome of Canine Mammary Tumors

SIMPLE SUMMARY: Human epidermal growth factor receptor 2 (HER2) participates in breast cancer pathogenesis and progression. However, the role of HER2 in canine mammary tumors is not completely understood, and data from different immunohistochemical studies are conflicting. A remarkable genetic varia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Canadas-Sousa, Ana, Santos, Marta, Dias-Pereira, Patrícia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135387/ https://www.ncbi.nlm.nih.gov/pubmed/37106947 http://dx.doi.org/10.3390/ani13081384

Ejemplares similares

Estrogen receptors genotypes and canine mammary neoplasia
por: Canadas-Sousa, Ana, et al.
Publicado: (2019)

Retrospective study of canine cutaneous tumors submitted to a diagnostic pathology laboratory in Northern Portugal (2014–2020)
por: Martins, Ana Luísa, et al.
Publicado: (2022)

Evaluation of myeloid metaplasia in canine mixed mammary tumors
por: Campos, Cecilia B, et al.
Publicado: (2013)

HER2 Overexpression and Cytogenetical Patterns in Canine Mammary Carcinomas
por: Muscatello, L. V., et al.
Publicado: (2022)

Effects of Lapatinib on HER2-Positive and HER2-Negative Canine Mammary Carcinoma Cells Cultured In Vitro
por: Leis-Filho, Antonio Fernando, et al.
Publicado: (2021)

Matrix metalloproteinases and their inhibitors in canine mammary tumors
por: Aresu, Luca, et al.
Publicado: (2011)

Current biomarkers of canine mammary tumors
por: Kaszak, Ilona, et al.
Publicado: (2018)

Metabolic Alterations in Canine Mammary Tumors
por: Tamarindo, Guilherme Henrique, et al.
Publicado: (2023)

Ultrasonography methods for predicting malignancy in canine mammary tumors
por: Feliciano, Marcus Antonio Rossi, et al.
Publicado: (2017)

Classification and grading of canine malignant mammary tumors
por: Tavasoly, Abbas, et al.
Publicado: (2013)

Prognostic phenotypic classification for canine mammary tumors
por: Varallo, Giovanna Rossi, et al.
Publicado: (2019)

Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas
por: Michel, Erika, et al.
Publicado: (2012)

Establishment and characterization of a HER2-enriched canine mammary cancerous myoepithelial cell line
por: Chen, Aolei, et al.
Publicado: (2023)

HER-2 and EGFR mRNA Expression and Its Relationship with Versican in Malignant Matrix-Producing Tumors of the Canine Mammary Gland
por: Damasceno, Karine Araújo, et al.
Publicado: (2016)

Alpha basic crystallin expression in canine mammary tumors
por: Guvenc, Tolga, et al.
Publicado: (2012)

Action of melatonin in primary culture of canine mammary tumors
por: Lopes, Juliana R, et al.
Publicado: (2013)

Evaluation of ATM protein expression in canine mammary tumors
por: Raposo, Talita MM, et al.
Publicado: (2013)

Expression and significance of CHIP in canine mammary gland tumors
por: WANG, Huanan, et al.
Publicado: (2015)

Significance of EZH2 expression in canine mammary tumors
por: Choi, Hyun-Ji, et al.
Publicado: (2016)

Comparative histopathology and immunohistochemistry of human and canine mammary tumors
por: Al-Mansour, Munsef A., et al.
Publicado: (2018)

Over-expression of mammaglobin-B in canine mammary tumors
por: Pandey, Mamta, et al.
Publicado: (2018)

Canine mammary tumors as a model for human disease
por: Abdelmegeed, Somaia M., et al.
Publicado: (2018)

Changes in Serum and Salivary Proteins in Canine Mammary Tumors
por: Franco-Martínez, Lorena, et al.
Publicado: (2020)

Specific urinary metabolites in canine mammary gland tumors
por: Valko-Rokytovská, Marcela, et al.
Publicado: (2020)

The Implication of Serum Autoantibodies in Prognosis of Canine Mammary Tumors
por: Yuan, Stephen Hsien-Chi, et al.
Publicado: (2022)

The Novel Diagnostic Techniques and Biomarkers of Canine Mammary Tumors
por: Kaszak, Ilona, et al.
Publicado: (2022)

Quantitative analysis of HER2 mRNA expression by RNA in situ hybridization in canine mammary gland tumors: Comparison with immunohistochemistry analysis
por: Seung, Byung-Joon, et al.
Publicado: (2020)

LncRNA Expression Profiles in Canine Mammary Tumors Identify lnc34977 as a Promoter of Proliferation, Migration and Invasion of Canine Mammary Tumor Cells
por: Lu, Baochun, et al.
Publicado: (2022)

Herceptin-sensitivity of HER2-transgenic mouse mammary tumors
por: Schwall, RH, et al.
Publicado: (2003)

PIK3CA is recurrently mutated in canine mammary tumors, similarly to in human mammary neoplasia
por: Arendt, Maja Louise, et al.
Publicado: (2023)

Comparative expression pathway analysis of human and canine mammary tumors
por: Uva, Paolo, et al.
Publicado: (2009)

Evaluation of c-KIT protein expression in canine mammary tumors
por: Salvador, Rosana CL, et al.
Publicado: (2013)

Altered oxidative stress and carbohydrate metabolism in canine mammary tumors
por: Jayasri, K., et al.
Publicado: (2016)

Identification and characterization of cancer stem cells in canine mammary tumors
por: Rybicka, Agata, et al.
Publicado: (2016)

Modeling molecular development of breast cancer in canine mammary tumors
por: Graim, Kiley, et al.
Publicado: (2021)

Lymphatic Drainage Mapping with Indirect Lymphography for Canine Mammary Tumors
por: Collivignarelli, Francesco, et al.
Publicado: (2021)

Metabolic Flexibility in Canine Mammary Tumors: Implications of the Carnitine System
por: Cacciola, Nunzio Antonio, et al.
Publicado: (2021)

Canine as a Comparative and Translational Model for Human Mammary Tumor
por: Kwon, Jee Young, et al.
Publicado: (2023)

Doxorubicin as a Potential Treatment Option in Canine Mammary Tumors
por: Gherman, Madalina Luciana, et al.
Publicado: (2023)

The Analysis of E-Cadherin, N-Cadherin, Vimentin, HER-2, CEA, CA15-3 and SF Expression in the Diagnosis of Canine Mammary Tumors
por: Yu, Chao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4op0a316pk2uce7g0tav3d1gf3